Fleishman-Hillard launches managed-markets division

Share this article:

Fleishman-Hillard is moving to cash in on the shift to managed markets with a new healthcare public affairs shop headed by Anne Woodbury, an associate of former Speaker Newt Gingrich, and Sharad Mansukani, one of the architects of the Medicare Modernization Act.
The Omnicom Group company is opening Fleishman-Hillard Health Solutions Navigator, a Washington, D.C., unit offering regulatory and policy communications, reimbursement consulting and media and government relations services including public opinion research, grassroots and coalition development, corporate and cause partnerships, issue
advertising and large-scale public education programs.  
Mansukani was a senior advisor and medical officer at the Center for Medicare and Medicaid Services, and served on the Bush Administration's Medicare Modernization Executive Committee. His focus at CMS was on prescription drug benefits, managed care enhancements and disease-management efforts, along with improving collaboration between CMS, the FDA and the NIH.
Woodbury, a longtime Gingrich aide, was most recently chief health advocate for the former House speaker's Center for Health Transformation.

 

Share this article:

Email Newsletters

More in News

Five things for pharma marketers to know: Thursday, August 21

Five things for pharma marketers to know: Thursday, ...

An Ebola survivor is set to leave Emory University Hospital, but the cause of the cure is uncertain, the FDA has approved a new type 1 diabetes test, and the ...

Sanofi expands Gaucher disease portfolio

Sanofi expands Gaucher disease portfolio

The oral medication Cerdelga joins Cerezyme in its Gaucher disease arsenal. Sanofi expects the drug will be priced "on par" with Cerezyme, which goes for around $300,000 a year in ...

Amicus seeks to upset Fabry market

Amicus seeks to upset Fabry market

Phase-III tests indicate patients may be able to switch from injectable enzyme-replacement therapies, like Fabrazyme, to the firm's oral drug.